Entrada Therapeutics
TRDA
#7220
Rank
NZ$0.68 B
Marketcap
$18.29
Share price
0.77%
Change (1 day)
-18.31%
Change (1 year)

Revenue for Entrada Therapeutics (TRDA)

Revenue in 2024 (TTM): NZ$0.35 Billion

According to Entrada Therapeutics's latest financial reports the company's current revenue (TTM ) is NZ$0.36 Billion. an increase over the revenue in the year 2023 that were of NZ$0.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Entrada Therapeutics from 2021 to 2024

20222023$0.1B$0.2B$0.3B$0.4B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 NZ$0.37 B83.2%
2023 NZ$0.20 B
2022 N/A
2021 N/A